Evidence map›Paper›PMID 33550974›Full record

ArticleCurrent neuropharmacology2022

Early Biomarkers and Intervention Programs for the Infant Exposed to Prenatal Stress.

Marta C Antonelli, Martin G Frasch, Mercedes Rumi, Ritika Sharma, Peter Zimmermann, Maria S Molinet, Silvia M Lobmaier

Abstract read
In one paragraph

Article in Current neuropharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Marta C AntonelliInstituto de Biología Celular y Neurociencia "Prof. E. De Robertis", Facultad de Medicina, UBA, Buenos Aires,Argentina | Department of Obstetrics and Gynecology, Klinikum rechts der Isar, Technical University of Munich, Germany.
Martin G FraschDepartment of Obstetrics and Gynecology, University of Washington, Seattle, WA,United States.
Mercedes RumiInstituto de Biología Celular y Neurociencia "Prof. E. De Robertis", Facultad de Medicina, UBA, Buenos Aires,Argentina.
Ritika SharmaDepartment of Obstetrics and Gynecology, Klinikum rechts der Isar, Technical University of Munich,Germany | Research Unit of Molecular Epidemiology, Institute of Epidemiology, Helmholtz Zentrum Munich, Neuherberg, Germany.
Peter ZimmermannDepartment of Obstetrics and Gynecology, Klinikum rechts der Isar, Technical University of Munich,Germany.
Maria S MolinetDepartment of Obstetrics and Gynecology, Klinikum rechts der Isar, Technical University of Munich,Germany.
Silvia M LobmaierDepartment of Obstetrics and Gynecology, Klinikum rechts der Isar, Technical University of Munich,Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Functional development of affective and reward circuits, cognition and response inhibition later in life exhibits vulnerability periods during gestation and early childhood. Extensive evidence supports the model that exposure to stressors in the gestational period and early postnatal life increases an individual's susceptibility to future impairments of functional development. Recent versions of this model integrate epigenetic mechanisms of the developmental response. Their understanding will guide the future treatment of the associated neuropsychiatric disorders. A combination of non-invasively obtainable physiological signals and epigenetic biomarkers related to the principal systems of the stress response, the Hypothalamic-Pituitary axis (HPA) and the Autonomic Nervous System (ANS), are emerging as the key predictors of neurodevelopmental outcomes. Such electrophysiological and epigenetic biomarkers can prove to timely identify children benefiting most from early intervention programs. Such programs should ameliorate future disorders in otherwise healthy children. The recently developed Early Family-Centered Intervention Programs aim to influence the care and stimuli provided daily by the family and improving parent/child attachment, a key element for healthy socio-emotional adult life. Although frequently underestimated, such biomarker-guided early intervention strategy represents a crucial first step in the prevention of future neuropsychiatric problems and in reducing their personal and societal impact.

Indexed as

Hypothalamo-Hypophyseal SystemPituitary-Adrenal SystemBiomarkersChildChild, PreschoolEpigenesis, GeneticEpigenomicsFemaleHumansInfantPregnancyBiomarkersearly intervention programsepigenetic biomarkersFHRMaternal stressneurodevelopmentPRSA

Identifiers

PMID33550974
PMCPMC9199558

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.